₹ 239.32
0.69 (0.29%)
P
Piramal Pharma
₹ 239.32
Piramal Pharma Fundamentals
Company Valuation
Market Cap (₹ Cr.)
31,862
PE Ratio
-152.10
PB Ratio
3.90
Dividend Yield
0.06%
ROE
-3.99%
ROCE
1.25%
Book Value (₹)
61.18
Face Value (₹)
10.00
Analyse PPLPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 34.86% | 34.86% | 34.86% | 34.80% | 34.80% |
| Domestic Institutional Investors (DII) | 14.89% | 15.69% | 15.61% | 14.57% | 14.44% |
| Foreign Institutional Investors (FII) | 30.27% | 29.66% | 30.18% | 12.52% | 13.65% |
| Public Investors | 14.12% | 14.11% | 13.74% | 14.54% | 13.27% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
PPLPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Smallcap
BSE Scrip Code
543635
NSE Scrip Name
PPLPHARMA
ISIN
INE0DK501011
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






